Aurizon Ear Drops, Suspension
Aurizon Ear Drops, Suspension
Authorised
- Marbofloxacin
- Dexamethasone acetate
- Clotrimazole
Product identification
Medicine name:
AURIZON EAR DROPS, SUSPENSION
Aurizon Ear Drops, Suspension
Active substance:
- Marbofloxacin
- Dexamethasone acetate
- Clotrimazole
Target species:
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Marbofloxacin3.00/milligram(s)1.00millilitre(s)
-
Dexamethasone acetate1.00/milligram(s)1.00millilitre(s)
-
Clotrimazole10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Available in:
-
United Kingdom (Northern Ireland)
Package description:
- Box containing 1 x 10 ml bottle
- Box containing 1 x 30 ml bottle
- Box containing 1 x 20 ml bottle
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- VETOQUINOL
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 06462/3029
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0124/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 12/06/2025
